Home › Gilead: What's Ahead In 2015 For This Biotech Juggernaut
 

Keywords :   


Gilead: What's Ahead In 2015 For This Biotech Juggernaut

2014-12-21 00:05:58| Biotech - Topix.net

Biotech juggernaut Gilead Sciences has provided its shareholders with better than a 30% gain in 2014 so far as we head into the end of the year. Although the stock has spent the last three months consolidating those gains in a relatively narrow trading range, the direction for 2015 remains up.

Tags: ahead biotech juggernaut gilead

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.10Tropical Depression Fourteen Graphics
05.10Tropical Depression Fourteen Forecast Discussion Number 1
05.10Tropical Depression Fourteen Wind Speed Probabilities Number 1
05.10Tropical Depression Fourteen Public Advisory Number 1
05.10Summary for Tropical Depression Fourteen (AT4/AL142024)
05.10Tropical Depression Fourteen Forecast Advisory Number 1
05.10Hurricane Kirk Graphics
05.10Hurricane Kirk Forecast Discussion Number 25
More »